Well-distribution modulo one and the primes

Autor: Champagne, J., Lê, T. H., Liu, Y. -R., Wooley, T. D.

Let $(p_n)$ denote the sequence of prime numbers, with $2=p_1Comment: 4 pages

Externí odkaz: http://arxiv.org/abs/2406.19491

On the Gas Content, Star Formation Efficiency, and Environmental Quenching of Massive Galaxies in Proto-Clusters at z~2.0-2.5

Autor: Zavala, Jorge A., Casey, C. M., Champagne, J. B., Chiang, Y., Dannerbauer, H., Drew, P., Fu, H., Spilker, J., Spitler, L., Tran, K. V., Treister, E., Toft, S.

We present ALMA Band 6 (nu=233GHz, lambda=1.3mm) continuum observations towards 68 'normal' star-forming galaxies within two Coma-like progenitor structures at z=2.10 and 2.47, from which ISM masses are derived, providing the largest census of molecu

Externí odkaz: http://arxiv.org/abs/1910.13457

The impact of comparative genomic hybridization/single-nucleotide polymorphism microarray in risk stratification of pediatric acute lymphoblastic leukemia.

Autor: Gourmel A; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada., Perrault H; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada., Colaiacovo ML; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada., Laramée L; Axis of Immune Diseases and Cancer, CHU Sainte-Justine Research Center, Montréal, Québec, Canada., Rozendaal M; Axis of Immune Diseases and Cancer, CHU Sainte-Justine Research Center, Montréal, Québec, Canada., Bittencourt H; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada.; Axis of Immune Diseases and Cancer, CHU Sainte-Justine Research Center, Montréal, Québec, Canada., Laverdière C; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada.; Axis of Immune Diseases and Cancer, CHU Sainte-Justine Research Center, Montréal, Québec, Canada., Champagne J; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada.; Axis of Immune Diseases and Cancer, CHU Sainte-Justine Research Center, Montréal, Québec, Canada., Cellot S; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada.; Axis of Immune Diseases and Cancer, CHU Sainte-Justine Research Center, Montréal, Québec, Canada., Silverman LB; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts, USA., Lemyre E; Department of Laboratory Medicine, CHU Sainte-Justine, Montréal, Québec, Canada., Maftei C; Department of Laboratory Medicine, CHU Sainte-Justine, Montréal, Québec, Canada., Mathonnet G; Department of Laboratory Medicine, CHU Sainte-Justine, Montréal, Québec, Canada., Tihy F; Department of Laboratory Medicine, CHU Sainte-Justine, Montréal, Québec, Canada., Pelland-Marcotte MC; Division of Hematology/Oncology, Department of Pediatrics, CHU de Québec-Centre Mère Enfant-Soleil, Québec City, Québec, Canada., Léveillé F; Department of Laboratory Medicine, CHU Sainte-Justine, Montréal, Québec, Canada., Tran TH; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada.; Axis of Immune Diseases and Cancer, CHU Sainte-Justine Research Center, Montréal, Québec, Canada.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31129. Date of Electronic Publication: 2024 Jul 02.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cell Therapy in Preclinical Models of Sepsis: A Systematic Review and Meta-analysis.

Autor: Hum C; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Tahir U; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Mei SHJ; Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Champagne J; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Fergusson DA; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Lalu M; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cell and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.; Department of Anesthesiology and Pain Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada., Stewart DJ; Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cell and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Walley K; Department of Medicine, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada., Marshall J; Department of Surgery (Critical Care), University of Toronto, Toronto, ON, Canada., Dos Santos CC; Keenan Research Centre for Biomedical Science and Interdepartmental Division of Critical Care, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada., Winston BW; Department of Critical Care Medicine, University of Calgary, Calgary, AB, Canada., Mendelson AA; Section of Critical Care Medicine, Department of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada., Dave C; Division of Critical Care Medicine, Department of Medicine, Western University, London, ON, Canada., McIntyre L; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Medicine (Division of Critical Care), University of Ottawa, Ottawa, ON, Canada.; Department of Medicine (Critical Care), The Ottawa Hospital, Ottawa Hospital Research Institute, Centre for Transfusion and Critical Care Research, Ottawa, ON, Canada.

Publikováno v: Stem cells translational medicine [Stem Cells Transl Med] 2024 Apr 15; Vol. 13 (4), pp. 346-361.